Susan J Rogers, MD | |
441 N Wabash Ave, Marion, IN 46952-2612 | |
(765) 662-4648 | |
Not Available |
Full Name | Susan J Rogers |
---|---|
Gender | Female |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 441 N Wabash Ave, Marion, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043439011 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 01022857A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Susan J Rogers, MD Po Box 308, Marion, IN 46952-0308 Ph: (765) 998-2572 | Susan J Rogers, MD 441 N Wabash Ave, Marion, IN 46952-2612 Ph: (765) 662-4648 |
News Archive
The drug aflibercept (trade name: Zaltrap) has been approved in Germany since February 2013 in combination with a certain chemotherapy for adults with metastatic colorectal cancer in whom chemotherapy with oxaliplatin could not stop the disease from progressing.
For women receiving breast implants during reconstructive or cosmetic breast surgery, scarring around the implant - called capsular contracture - is a common, costly, and painful complication.
While conducting more clinical trials in developing countries can help under-represented populations benefit from new medical developments, trials in low-income settings face challenges such as complicated regulations, Trudie Lang of the Centre for Tropical Medicine at the University of Oxford and Sisira Siribaddana of the University of Rajarata and the Institute of Research & Development in Sri Lanka write in an essay published Tuesday in PLoS Medicine.
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1 study of ISIS-FXIRx, an antisense drug designed to treat clotting disorders. ISIS-FXIRx inhibits the production of Factor XI, a clotting factor that is an important component of the coagulation pathway. Because of its role in the intrinsic coagulation pathway, inhibition of Factor XI could offer an effective approach for preventing the formation of blood clots with a lower risk of bleeding.
Older adults on a walk or hike, or just going about their daily routines, seem to experience greater fatigue than their younger counterparts. Such fatigue may ultimately affect their ability to participate in activities that are meaningful to them and help keep them healthy.
› Verified 8 days ago
Kenneth Edward Gallagher, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 441 N Wabash Ave, Marion, IN 46952 Phone: 765-662-4648 | |
Dean B Ricks, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 441 N Wabash Ave, Marion, IN 46952 Phone: 765-662-4648 |